Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-08

Clinical Trial Update: Midazolam Drug-Drug Interaction Study With Lurasidone HCl [Phase 1]

View source ↗

Summary

Phase 1 study completed to evaluate the pharmacokinetic interaction and safety between midazolam and lurasidone hydrochloride in schizophrenia patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Latuda (lurasidone)
  • Midazolam (Midazolam)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Schizophrenia Patients | Phase 1 | Status: COMPLETED